# Safety and Efficacy of AGN 203818 for Pain Associated With Painful Bladder Syndrome/Interstitial Cystitis

> **NCT00380783** · PHASE2 · TERMINATED · sponsor: **Allergan** · enrollment: 2 (actual)

## Conditions studied

- Cystitis, Interstitial

## Interventions

- **DRUG:** AGN 203818

## Key facts

- **NCT ID:** NCT00380783
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-10
- **Primary completion:** 2007-03
- **Final completion:** 2007-03
- **Target enrollment:** 2 (ACTUAL)
- **Last updated:** 2011-05-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00380783

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00380783, "Safety and Efficacy of AGN 203818 for Pain Associated With Painful Bladder Syndrome/Interstitial Cystitis". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00380783. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*